Tvardi Therapeutics Inc. said it appointed Imran Alibhai as the company's CEO and board member, effective immediately.
Previously, Alibhai served as senior vice president and managing director at DNAtrix Inc. He was also an investment banker in PJ Solomon LP's healthcare advisory group. In addition, he held investing roles at Accelerator Corp., Alexandria Venture Investments LLC and MPM Capital.
Houston-based Tvardi Therapeutics is a biotechnology company that develops medicines for the treatment of cancer, chronic inflammation and fibrosis.